ENTREPRENEUR -- 2 (Shanghvi)

                  DILIP SHANGHVI

DILIP SHANGHVI

Age                             ---       59

Source Of Wealth     ---      pharmaceuticals, Self Made

Residence                  ---         Mumbai, India

Citizenship                ---      India

Education                  ---               Bachelor of Arts,                                               Calcutta  

         

            Dilip Shanghvi started Sun Pharmaceutical Industries with capital of Rs 10,000 in 1982. Shanghvi founded Sun Pharmaceuticals in 1983 with five psychiatry products. Today, it is India's largest drugmaker and most valuable drug company. Appreciation of Sun's stock led to a 50% surge in his personal wealth, amounting to USD 4.7 billion. As of August 2014, He has a net worth of $19 billion, according to the Bloomberg Billionaire's Index. He has also been named in the list of Asia’s top ten wealthiest self-made billionaires, according to Wealth-X. Shanghvi is also the Chairman and Managing Director of Sun Pharma Advanced Research Company and Shantilal Shanghvi Foundation.

        In 1997, he acquired Caraco Pharma, a loss-making American company, with the aim of expanding Sun's reach in the United States and turned them around in no time. Both the deals have paid off; the US now accounts for 60% of Sun's revenue. He also acquired Israel's Taro Pharma in 2007. He is also credited with steering Sun Pharma to fifth place in the global generic drugs market.

       On 19 February 2015, he surpassed Mukesh Ambani as the richest person of India, as his parent company stocks surges.

Dilip Shanghvi, founder of Sun Pharmaceutical Industries, India's most valuable drug company (market cap:$31 billion), is now the country's second-richest person, after Reliance Industries' Mukesh Ambani. 

SUN PHARMA COMPANY SNAP

 About Sun Pharmaceuticals Company

       It was established by Mr. Dilip Shanghvi .It was in 1982 with just 10000Rs he started the pharma company. Now it is a multinational pharmaceutical company. 

 

      It manufactures and sells in various therapeutic areas, such as Cardiology,psychiatry,gastroentrology,and diabetology. It also provides such as warfarin, carbamazepine, etodolac, and clorazepate, as well as anticancers, steroids, peptides, sex hormones, and controlled substances.

     Over 72% of Sun Pharma sales are from markets outside Indiaprimarily in the US .The US is the single largest market, accounting for about 60% turnover

   ACCORDING TO FROBES 

         According to frobes Dilip Shanghvi,founder of sunpharma industry most valuable drug company.He becames The Second-richest person in India,overtaking steel tycoon Lakshmi Mittal.

         According to frobes Dilip shanghvi is 44^th richest person in Global.Real time net worth is $18.8Billion....

          In  2014 Frobes Magazine awarded as a "ENTREPRENEUR OF THE YEAR".